Europe · Markets & Finance · Finanz und Wirtschaft

Alcon: FDA lässt rezeptfreie Augentropfen Brytly zu

Published by Finanz und Wirtschaft · Switzerland 1 d ago

Alcon hat in den USA eine Zulassung für neue rezeptfreie Augentropfen erhalten. Die US-Gesundheitsbehörde FDA gab grünes Licht für das Präparat Brytly zur Linderung von…

Read the full article on Finanz und Wirtschaft Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fuw.ch)

Also worth reading

Financial Times

Zelenskyy says Starlink speed limits in Ukraine are a ‘planned operation’

This is Money

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

City A.M.

Alcon: FDA lässt rezeptfreie Augentropfen Brytly zu

Share

Also worth reading

Zelenskyy says Starlink speed limits in Ukraine are a ‘planned operation’

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

These are the best literary hotels in Europe

Exotic species appear off California thanks to an unusually strong El Niño

BOJ may need to tighten faster if inflation beats forecast, IMF says

Celestia jumps 57% to 11-month high as 7 altcoins beat the market